Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

It Takes Two: FDA Reorganizes Office Of Information Management

Executive Summary

Taha Kass-Hout has begun his tenure as Chief Informatics Officer, focusing on scientific computing; the agency expects to hire a Chief Information Officer within 60 to 90 days to handle software development and deployment and infrastructure.

You may also be interested in...



FDA Seeks New Chief Information Officer In Privacy And Security Overhaul

The CIO will help develop policy to protect sensitive information while balancing individual privacy and security. FDA restructured the organization with a chief health informatics officer – focused on research, development, scientific computing and big data – and the CIO for software development and deployment, infrastructure and customer service.

FDA Seeks New Chief Information Officer In Privacy And Security Overhaul

The CIO will help develop policy to protect sensitive information while balancing individual privacy and security. FDA restructured the organization with a chief health informatics officer – focused on research, development, scientific computing and big data – and the CIO for software development and deployment, infrastructure and customer service.

FDA Seeks New Chief Information Officer As Privacy And Security Policies Get Overhaul

New CIO will help develop new policy to protect sensitive information at FDA, while also balancing individual privacy and security.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS055351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel